Latest News

In a review of nearly 1,300 emergency referrals for computed tomography (CT) scans, approximately 28 percent were deemed to have adequate requisition quality according to a RI-RADS analysis.

Noting an increased incidence of false negatives in screening and diagnostic mammography, researchers found that a personal history of breast cancer was associated with over a 3.6-fold higher likelihood of false negatives.

Use of the radiotherapeutic agent 177Lu-edotreotide (ITM-11) demonstrated significantly higher absorption in gastroenteropancreatic neuroendocrine tumors than normal organs along with a favorable safety profile, according to SPECT research recently presented at the European Association of Nuclear Medicine (EANM) conference.

Facilitating timely triage, the qER-CTA software enables AI assessment of the internal carotid artery and M1 segment of the middle cerebral artery for possible large vessel occlusions (LVOs).

Pre-op breast MRI was associated with a 12.5 percent reduced 5-year cumulative incidence of recurrence for patients who underwent surgery for hormone receptor-negative cancer, according to newly published research.

In a recent interview, Deepa Sheth, M.D., discussed the rising incidence of breast cancer, key considerations in supplemental imaging for women with dense breasts and use of the CIVIE RadPod platform to facilitate consistent quality and imaging reads by fellowship-trained breast radiologists.

Deep learning assessment of MRI offered a 24 percent higher sensitivity than radiologist interpretation for detecting lymph node metastasis in patients with colorectal cancer, according to a new meta-analysis.

Through the use of a multimodal system, Viz Assist provides generative AI summaries of patient histories that may ehance care coordination and facilitate more timely interventions.

Pluvicto in combination with the standard of care led to a 28 percent reduction in the risk of radiographic progression or death in patients with metastatic hormone-sensitive prostate cancer (mHSPC), according to results from the phase III PSMAddition trial presented at the European Society for Medical Oncology (ESMO) conference.

Catch up on the top radiology content of the past week.

The iron-based brain MRI contrast agent Ferabright (ferumoxytol injection) is indicated for adult patients with known or suspected malignant neoplasms.

Concordant mammography detection of breast cancer by radiologists and AI had over a threefold higher likelihood of future incidental breast cancer in comparison to positive radiologist assessment and negative AI evaluation, according to new research involving over 82,000 women.

The AI-enabled LungQ® 4 software reportedly offers enhanced segmentation of peripheral airways and estimates of chronic perfusion deficits based on analysis of chest CT scans.